On November 18, 2013, the U.S. Senate passed the Drug Quality and Security Act, which would
amend the Food, Drug, and Cosmetic Act. The bill
was originally introduced in the House of Representatives (as H.R.
3204) and would alter the
regulation of compounded drugs. The Bill was passed in the
Senate without amendment, as several efforts to amend it were
withdrawn or fell.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.